中文 | English
Return
Total: 6255 , 1/626
Show Home Prev Next End page: GO
Author:(Ren WANG)

1.The expression and significance of survivin in hepatocellular carcinoma: a Meta-analysis

Chaoyi REN ; Yijun WANG

Chinese Journal of Hepatobiliary Surgery 2014;20(2):113-118

2.Chiral selective effects of doxazosin and its enantiomers on cell proliferation in cultured vascular smooth muscle cells of the rat aorta

Rongying WANG ; Leiming REN

Chinese Pharmacological Bulletin 1987;0(01):-

3.Protective effect of glutamine on acute hepatic injury

Weiqiang WANG ; Chengshan REN

Journal of Third Military Medical University 2003;0(11):-

4.Advancement of target therapy in endometrial cancer

Yulan REN ; Huaying WANG

China Oncology 2001;0(05):-

5.Association of polymorphism of CTLA-4 gene exon 1 with Graves′ disease in Chinese population

Qiaohong WANG ; Yuezhong REN

Chinese Journal of Endocrinology and Metabolism 1986;0(04):-

6.Application of the Montreal Cognitive Assessment in early screening in patients with vascular cognitive impairment-no dementia

Muqiu WANG ; Mingshan REN

International Journal of Cerebrovascular Diseases 2011;19(12):921-924

7.Relationship between inflammation and macroangiopathy in type 2 diabetes mellitus and the protective role of pioglitazone in macroangiopathy

Xiaoying REN ; Zhanjian WANG

Chinese Journal of Diabetes 2008;16(8):491-492

8.Relaxation and contraction induced by ATP via P2 receptors in longitudinal muscle strips of the rat proximal colon

Leiming REN ; Miao WANG

Chinese Journal of Pharmacology and Toxicology 2005;19(5):321-326

9.Research progress on anaerobic bacteria in tuomr gene therapy

Liying WANG ; Rueimei REN

Journal of International Oncology 2010;37(9):665-667

10.Influence of Hiwigene targeting silence in chemotherapy sensitivity of breast cancer MCF-7/ADM cells

Aihua REN ; Dawei WANG

Journal of Jilin University(Medicine Edition) 2017;43(4):743-746

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 6255 , 1/626 Show Home Prev Next End page: GO